Skip to main content

Table 2 Univariate analysis of clinical factors in predicting failure pattern

From: Predictive model of the first failure pattern in patients receiving definitive chemoradiotherapy for inoperable locally advanced non-small cell lung cancer (LA-NSCLC)

Characteristic

Local failure

(n = 46)

Distant failure

(n = 54)

Chi-square test

P value

FDR correction

Q value

Sex

  

0.035

0.093

Female

5 (25.0%)

15 (75.0%)

  

Male

41 (51.2%)

39 (48.8%)

  

Smoking

  

0.027

0.093

No

13 (32.5%)

27 (67.5%)

  

Yes

33 (55.0%)

27 (45.0%)

  

Pathology

  

0.031

0.093

Squamous cell carcinoma

24 (61.5%)

15 (38.5%)

  

Non-small cell carcinoma

3 (25.0%)

9 (75.0%)

  

Adenocarcinoma

19 (38.8%)

30 (61.2%)

  

Tumor diameter

  

0.284

0.432

≤3 cm

13 (37.1%)

22 (62.9%)

  

> 3 cm, ≤5 cm

20 (55.6%)

16 (44.4%)

  

> 5 cm, ≤7 cm

10 (52.6%)

9 (47.4%)

  

> 7 cm

3 (30.0%)

7 (70.0%)

  

Location

  

0.012

0.093

Central

25 (61.0%)

16 (39.0%)

  

Peripheral

21 (35.6%)

38 (64.4%)

  

EGFR

  

0.018

0.093

Wild

40 (52.6%)

36 (47.4%)

  

Mutant

6 (25%)

18 (75%)

  

Clinical T stage

  

0.260

0.432

cT1

10 (32.3%)

21 (67.7%)

  

cT2

18 (54.5%)

15 (45.5%)

  

cT3

11 (55.0%)

9 (45.0%)

  

cT4

7 (43.8%)

9 (56.3%)

  

Clinical N stage

  

0.297

0.432

cN0–1

5 (71.4%)

2 (28.6%)

  

cN2

25 (47.2%)

28 (52.8%)

  

cN3

16 (40.0%)

24 (60.0%)

  

Clinical TNM stage

  

0.267

0.432

cIIIA

19 (52.8%)

17 (47.2%)

  

cIIIB

23 (39.7%)

35 (60.3%)

  

cIIIC

4 (66.7%)

2 (33.3%)

  

Sequence of CRT

  

0.566

0.604

Concurrent

17(37.0%)

29(63.0%)

  

Sequential

23(42.6%)

31(57.4%)

  

Consolidation chemotherapy

  

0.087

0.199

No

22(38.6%)

35(61.4%)

  

Yes

24(55.8%)

19(44.2%)

  

Radiation Dose

  

0.405

0.498

< 60 Gy

5 (35.7%)

9 (64.3%)

  

≥60 Gy

41 (47.7%)

45 (52.3%)

  

*Age (y) (continuous variable)

m#61.5(38–83)

m#59(22–73)

0.026

0.093

*Primary tumor volume (cm3)

m#47.04(5.12–383.14)

m#38.17(0.89–392.9)

0.377

0.498

*Lymph nodal volume (cm3)

m#62.68(0–241.92)

m#65.69(0–335.86)

0.966

0.966

*Total volume (cm3)

m#142.84(19.79–473.64)

m#129.58(27.25–481.28)

0.487

0.557

  1. CRT chemoradiotherapy
  2. # For continuous variables, “m” means median, and ranges of variables are in parentheses. *For these continuous variables, Wilcoxon rank-sum test was used